Literature DB >> 20575024

Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia.

Clara Deambrogi, Lorenzo De Paoli, Marco Fangazio, Stefania Cresta, Silvia Rasi, Valeria Spina, Valter Gattei, Gianluca Gaidano, Davide Rossi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20575024      PMCID: PMC7159449          DOI: 10.1002/ajh.21742

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  11 in total

1.  Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.

Authors:  Carsten Schwaenen; Michelle Nessling; Swen Wessendorf; Tatjana Salvi; Gunnar Wrobel; Bernhard Radlwimmer; Hans A Kestler; Christian Haslinger; Stephan Stilgenbauer; Hartmut Döhner; Martin Bentz; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-16       Impact factor: 11.205

2.  The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

Authors:  Davide Rossi; Michaela Cerri; Clara Deambrogi; Elisa Sozzi; Stefania Cresta; Silvia Rasi; Lorenzo De Paoli; Valeria Spina; Valter Gattei; Daniela Capello; Francesco Forconi; Francesco Lauria; Gianluca Gaidano
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

3.  Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.

Authors:  Elise Chapiro; Nathalie Leporrier; Isabelle Radford-Weiss; Christian Bastard; Hossein Mossafa; Dominique Leroux; Isabelle Tigaud; Marc De Braekeleer; Christine Terré; Françoise Brizard; Evelyne Callet-Bauchu; Stéphanie Struski; Lauren Veronese; Sandra Fert-Ferrer; Sylvie Taviaux; Claude Lesty; Frédéric Davi; Hélène Merle-Béral; Olivier A Bernard; Laurent Sutton; Sophie D Raynaud; Florence Nguyen-Khac
Journal:  Leuk Res       Date:  2009-04-29       Impact factor: 3.156

4.  Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.

Authors:  C Haferlach; F Dicker; S Schnittger; W Kern; T Haferlach
Journal:  Leukemia       Date:  2007-09-06       Impact factor: 11.528

5.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Authors:  B D Cheson; J M Bennett; M Grever; N Kay; M J Keating; S O'Brien; K R Rai
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

6.  Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

Authors:  Dietmar Pfeifer; Milena Pantic; Ilona Skatulla; Justyna Rawluk; Clemens Kreutz; Uwe M Martens; Paul Fisch; Jens Timmer; Hendrik Veelken
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

7.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

8.  Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Authors:  Valter Gattei; Pietro Bulian; Maria Ilaria Del Principe; Antonella Zucchetto; Luca Maurillo; Francesco Buccisano; Riccardo Bomben; Michele Dal-Bo; Fabrizio Luciano; Francesca M Rossi; Massimo Degan; Sergio Amadori; Giovanni Del Poeta
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

9.  Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.

Authors:  Davide Rossi; Valeria Spina; Michaela Cerri; Silvia Rasi; Clara Deambrogi; Lorenzo De Paoli; Luca Laurenti; Rossana Maffei; Francesco Forconi; Francesco Bertoni; Emanuele Zucca; Claudio Agostinelli; Antonello Cabras; Marco Lucioni; Maurizio Martini; Michele Magni; Silvia Deaglio; Marco Ladetto; Josep F Nomdedeu; Caroline Besson; Antonio Ramponi; Vincenzo Canzonieri; Marco Paulli; Roberto Marasca; Luigi M Larocca; Antonino Carbone; Stefano A Pileri; Valter Gattei; Gianluca Gaidano
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

10.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

Authors:  E Matutes; K Owusu-Ankomah; R Morilla; J Garcia Marco; A Houlihan; T H Que; D Catovsky
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

View more
  6 in total

1.  Identification of sequence variants influencing immunoglobulin levels.

Authors:  Stefan Jonsson; Gardar Sveinbjornsson; Aitzkoa Lopez de Lapuente Portilla; Bhairavi Swaminathan; Rosina Plomp; Gillian Dekkers; Ram Ajore; Mina Ali; Arthur E H Bentlage; Evelina Elmér; Gudmundur I Eyjolfsson; Sigurjon A Gudjonsson; Urban Gullberg; Arnaldur Gylfason; Bjarni V Halldorsson; Markus Hansson; Hilma Holm; Åsa Johansson; Ellinor Johnsson; Aslaug Jonasdottir; Bjorn R Ludviksson; Asmundur Oddsson; Isleifur Olafsson; Sigurgeir Olafsson; Olof Sigurdardottir; Asgeir Sigurdsson; Lilja Stefansdottir; Gisli Masson; Patrick Sulem; Manfred Wuhrer; Anna-Karin Wihlborg; Gudmar Thorleifsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Gestur Vidarsson; Ingileif Jonsdottir; Björn Nilsson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

2.  Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation.

Authors:  Karin Klauke; Višnja Radulović; Mathilde Broekhuis; Ellen Weersing; Erik Zwart; Sandra Olthof; Martha Ritsema; Sophia Bruggeman; Xudong Wu; Kristian Helin; Leonid Bystrykh; Gerald de Haan
Journal:  Nat Cell Biol       Date:  2013-03-17       Impact factor: 28.824

3.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

4.  Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.

Authors:  Ilaria Del Giudice; Marilisa Marinelli; Jiguang Wang; Silvia Bonina; Monica Messina; Sabina Chiaretti; Caterina Ilari; Luciana Cafforio; Sara Raponi; Francesca Romana Mauro; Valeria Di Maio; Maria Stefania De Propris; Mauro Nanni; Carmela Ciardullo; Davide Rossi; Gianluca Gaidano; Anna Guarini; Raul Rabadan; Robin Foà
Journal:  Br J Haematol       Date:  2015-11-24       Impact factor: 6.998

5.  Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

Authors:  Zijun Y Xu-Monette; Meifeng Tu; Kausar J Jabbar; Xin Cao; Alexandar Tzankov; Carol Visco; Lalitha Nagarajan; Qingqing Cai; Santiago Montes-Moreno; Yuji An; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Michael B Møller; John P Farnen; Jane N Winter; Miguel A Piris; Roberto N Miranda; L Jeffrey Medeiros; Ken H Young
Journal:  Oncotarget       Date:  2015-03-20

6.  Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells.

Authors:  Yaru Sheng; Zhongzhong Ji; Huifang Zhao; Jinming Wang; Chaping Cheng; Weimin Xu; Xue Wang; Yuman He; Kaiyuan Liu; Li Li; Thibault Voeltzel; Veronique Maguer-Satta; Wei-Qiang Gao; Helen He Zhu
Journal:  Cell Prolif       Date:  2019-05-03       Impact factor: 6.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.